Taiyen Biotech Co Ltd (1737) — Free Cash Flow Generation Index
Taiyen Biotech Co Ltd (1737) has a Free Cash Flow Generation Index of 0.62x as of June 2026. Free cash flow of NT$61.77 Million represents 1% of operating cash flow (NT$99.80 Million). Explore how much does Taiyen Biotech Co Ltd reinvest in capital to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Taiyen Biotech Co Ltd Free Cash Flow Generation Index (2003–2025)
Historical FCF Generation Index trend for Taiyen Biotech Co Ltd across 23 annual periods. For the full cash flow conversion analysis, see Taiyen Biotech Co Ltd (1737) cash conversion ratio.
Annual Free Cash Flow Generation for Taiyen Biotech Co Ltd (2003–2025)
Year-by-year Free Cash Flow Generation Index for Taiyen Biotech Co Ltd. Check cash flow reinvestment rate of Taiyen Biotech Co Ltd to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (TWD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.37x | NT$173.60 Million | NT$473.77 Million | NT$300.16 Million | ▼ -31.4% |
| 2024 | 0.53x | NT$352.51 Million | NT$660.12 Million | NT$307.61 Million | ▲ +121.9% |
| 2023 | 0.24x | NT$109.41 Million | NT$454.54 Million | NT$345.13 Million | ▼ -58.2% |
| 2022 | 0.58x | NT$334.09 Million | NT$580.69 Million | NT$246.60 Million | ▲ +65.0% |
| 2021 | 0.35x | NT$209.26 Million | NT$600.08 Million | NT$390.81 Million | ▲ +65.6% |
| 2020 | 0.21x | NT$71.46 Million | NT$339.36 Million | NT$267.89 Million | ▲ +49.6% |
| 2019 | 0.14x | NT$46.56 Million | NT$330.81 Million | NT$284.25 Million | ▼ -58.2% |
| 2018 | 0.34x | NT$151.35 Million | NT$449.83 Million | NT$298.49 Million | ▼ -14.1% |
| 2017 | 0.39x | NT$238.18 Million | NT$607.87 Million | NT$369.68 Million | ▼ -41.1% |
| 2016 | 0.67x | NT$377.77 Million | NT$568.06 Million | NT$190.30 Million | ▼ -7.9% |
| 2015 | 0.72x | NT$277.36 Million | NT$383.93 Million | NT$106.57 Million | ▲ +20.6% |
| 2014 | 0.60x | NT$222.25 Million | NT$371.06 Million | NT$148.81 Million | ▲ +11.0% |
| 2013 | 0.54x | NT$109.68 Million | NT$203.21 Million | NT$93.53 Million | ▲ +85.0% |
| 2012 | 0.29x | NT$45.06 Million | NT$154.46 Million | NT$109.40 Million | ▼ -57.6% |
| 2011 | 0.69x | NT$169.24 Million | NT$246.09 Million | NT$76.85 Million | ▲ +18.4% |
| 2010 | 0.58x | NT$174.81 Million | NT$300.89 Million | NT$126.08 Million | ▼ -14.5% |
| 2009 | 0.68x | NT$243.36 Million | NT$358.02 Million | NT$114.67 Million | ▼ -53.4% |
| 2008 | 1.46x | NT$609.60 Million | NT$417.51 Million | NT$192.08 Million | ▲ +17.1% |
| 2007 | 1.25x | NT$402.19 Million | NT$322.49 Million | NT$79.70 Million | ▼ -5.6% |
| 2006 | 1.32x | NT$611.33 Million | NT$462.88 Million | NT$148.45 Million | ▲ +7.9% |
| 2005 | 1.22x | NT$705.10 Million | NT$575.91 Million | NT$129.19 Million | ▲ +14.6% |
| 2004 | 1.07x | NT$3.03 Billion | NT$2.84 Billion | NT$192.93 Million | ▲ +3.9% |
| 2003 | 1.03x | NT$3.51 Billion | NT$3.42 Billion | NT$94.39 Million | — |